scispace - formally typeset
S

Sanjeev Saksena

Researcher at Atlantic Health System

Publications -  174
Citations -  6606

Sanjeev Saksena is an academic researcher from Atlantic Health System. The author has contributed to research in topics: Atrial fibrillation & Cardioversion. The author has an hindex of 44, co-authored 169 publications receiving 6463 citations. Previous affiliations of Sanjeev Saksena include University of Minnesota & Newark Beth Israel Medical Center.

Papers
More filters
Journal ArticleDOI

A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia.

TL;DR: The clinical efficacy and safety of transvenous cardioversion for termination of sustained ventricular tachycardia (VT) were examined by a prospective randomized study design in 22 patients with organic heart disease and sustained VT.
Journal ArticleDOI

Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.

TL;DR: The use of axillary or pectoral patch lead location can allow endocardial defibrillation with biphasic shocks at energies s15 J in this lead configuration and Virtually universal application of endocardia defibrillation lead systems can be predicted from these data.
Journal ArticleDOI

Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias

TL;DR: Based on available data, ICD therapy is preferable as initial therapy in patients with malignant ventricular tachyarrhythmias and economic analyses show that drug therapy and device therapy are both within the range of other current cardiovascular therapies.
Journal ArticleDOI

Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia

TL;DR: It is concluded that implantable antitachycardia systems can be used successfully for noninvasive tachycardsia induction and termination and for reliable serial electrophysiologic studies.